title: Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy.
authors.forename: I
authors.initials: I
authors.lastname: Gentile
authors.forename: G
authors.initials: G
authors.lastname: Di Flumeri
authors.forename: S
authors.initials: S
authors.lastname: Scarica
authors.forename: A
authors.initials: A
authors.lastname: Frangiosa
authors.forename: M
authors.initials: M
authors.lastname: Foggia
authors.forename: L
authors.initials: L
authors.lastname: Reynaud
authors.forename: G
authors.initials: G
authors.lastname: Borgia
mesh_terms: D000208:Acute Disease; D000328:Adult; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006212:Hallucinations / Q000139:chemically induced; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000188:drug therapy* / Q000209:etiology; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012074:Remission Induction; D006435:Renal Dialysis / Q000009:adverse effects*; D012173:Retinitis / Q000139:chemically induced; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000139:chemically induced; D014766:Viremia / Q000188:drug therapy*
chemical_list: D018937:Hepatitis C Antibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins